Unknown

Dataset Information

0

Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors.

ABSTRACT: Eosinophils are attractive innate immune cells to use to potentiate T cell antitumor efficacy because they are capable of infiltrating tumors at early stages and modulating the tumor microenvironment. However, the limited number of functional eosinophils caused by the scarcity and short life of primary eosinophils in peripheral blood has greatly impeded the development of eosinophil-based immunotherapy. In this study, we established an efficient chemically defined protocol to generate a large quantity of functional eosinophils from human pluripotent stem cells (hPSCs) with nearly 100% purity expressing eosinophil peroxidase. These hPSC-derived eosinophils transcriptionally resembled their primary counterpart. Moreover, hPSC-derived eosinophils showed competent tumor killing capacity in established solid tumors. Furthermore, the combination of hPSC-derived eosinophils with CAR-T cells exhibited potential synergistic effects, inhibiting tumor growth and enhancing mouse survival. Our study opens up new avenues for the development of eosinophil-based immunotherapies to treat cancer.

SUBMITTER: Lai W 

PROVIDER: S-EPMC8282466 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors.

Lai Weifeng W   Xie Huangfan H   Liu Yuting Y   Zheng Feng F   Zhang Yingfeng Y   Lei Qi Q   Lv Lejun L   Dong Jiebin J   Song Jian J   Gao Xue X   Yin Ming M   Wang Chengyan C   Deng Hongkui H  

Stem cell reports 20210701 7

Eosinophils are attractive innate immune cells to use to potentiate T cell antitumor efficacy because they are capable of infiltrating tumors at early stages and modulating the tumor microenvironment. However, the limited number of functional eosinophils caused by the scarcity and short life of primary eosinophils in peripheral blood has greatly impeded the development of eosinophil-based immunotherapy. In this study, we established an efficient chemically defined protocol to generate a large qu  ...[more]

Similar Datasets

Unknown Cytotoxicity of activated natural killer cells against pediatric solid tumors.
| S-EPMC3168562 | biostudies-literature
Unknown Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model.
| S-EPMC6350694 | biostudies-literature
Unknown Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors.
| S-EPMC10507032 | biostudies-literature
Unknown Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.
| S-EPMC6468810 | biostudies-other
Transcriptomics Generation of eosinophils with potent antitumor activity from human pluripotent stem cells
2021-07-21 | GSE148907 | GEO
Transcriptomics B7-H3-Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity Against Solid Tumors
2024-08-22 | GSE275242 | GEO
Proteomics A Pluripotent Stem Cell-Derived Matrix with Potent Osteoregenerative Capabilities
2020-07-02 | PXD016017 | Pride
Unknown Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.
| S-EPMC3504383 | biostudies-literature
Unknown Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity.
| S-EPMC7934477 | biostudies-literature
Unknown Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.
| S-EPMC4086362 | biostudies-literature